Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/25/2000CN1270808A Preparation of antiphlogistic pain-stopping Chinese medicine
10/25/2000CN1270804A use of diphenyl styrene in cosmetic composition as deodoring active content
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/25/2000CN1057771C Androstenone derivative
10/25/2000CN1057770C Application of 19,11 beta-bridged sterodal compound in pharmaceutical working
10/25/2000CN1057769C Process for preparing 14 alpha, 17 alpha-bridged ethano-16 alpha-hydroxy-estratrienes medicinal compositions
10/25/2000CN1057768C Sterol compositions from pulping soap
10/25/2000CN1057767C Androstanes with inducing hypothalamic effects
10/25/2000CN1057760C Amino acid substituted benzoylguanidines, process for their preparation, their use and medicament containing them
10/25/2000CN1057759C Alkyl-5-methyl sulfonylbenzoy/guanidine
10/25/2000CN1057758C antiarrhythmic (S)-enantiomers of methanesulfonamides
10/25/2000CN1057673C Tablet, capsule, or granule comprising desogestrel
10/25/2000CN1057672C Medicine for curing cerebrovascular disease
10/25/2000CN1057671C Coated vitamin C preparation for animal feed, production and use thereof
10/24/2000US6137003 Bis (haloethyl) aminobenzene derivatives
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136989 Adding acetone to paclitaxel extract to form acetone mixture; contacting acetone mixture with aqueous solvent to form precipitate; recovering precipitate
10/24/2000US6136988 7-hexanoyltaxol and methods for preparing the same
10/24/2000US6136985 CLA esters and uses thereof
10/24/2000US6136984 Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
10/24/2000US6136978 Camptothecin analogs and methods of preparation thereof
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136969 Azepanes
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136864 Denaturants for sympathomimetic amine salts
10/24/2000US6136863 Antifungal agents
10/24/2000US6136862 Intravenously administering an organic acid, ester, or salt thereof
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136860 Use of L-lysine in the treatment of hair loss
10/24/2000US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier
10/24/2000US6136858 Mixture of vegetable oils
10/24/2000US6136857 Melanoma, leukemia, adenocancer
10/24/2000US6136855 Water-Miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
10/24/2000US6136851 Skin disorders
10/24/2000US6136850 Methods and compositions for inhibiting deposit formation on contact lenses
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136847 Water-soluble trioxanes as potent and safe antimalarial agents
10/24/2000US6136846 In water miscible solubilizer
10/24/2000US6136845 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl PCDFs
10/24/2000US6136844 5-aroylpyrrol-2-ylmethylarene derivatives
10/24/2000US6136843 Indole derivatives useful as endothelin receptor antagonists
10/24/2000US6136842 Sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136838 Administering by injection
10/24/2000US6136836 A 1-(3-chloro-4-(1,1,2-trifluoro-2-fluoromethoxyethoxy)phenyl-3-(2,6-difluorobenzoyl)urea
10/24/2000US6136835 Methods of treatment for viral infections
10/24/2000US6136833 Pharmaceutical formulations and process for their preparation
10/24/2000US6136832 Racemic mixtures and enantiomorphs
10/24/2000US6136829 Nitric oxide synthetase inhibitors
10/24/2000US6136828 Endothelin receptor antagonists
10/24/2000US6136827 Cyclic amine modulations of chemokine receptor activity
10/24/2000US6136825 Sulfonamide compounds having 5-HT receptor activity
10/24/2000US6136821 Naphthyridine derivatives
10/24/2000US6136820 Isolation of castanospermine and its use as an antidiabetic agent
10/24/2000US6136819 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/24/2000US6136818 Kits with mixtures for stiffnening in treatment of sexual problems
10/24/2000US6136817 Opioid receptor antagonist compounds
10/24/2000US6136815 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
10/24/2000US6136813 Viricides for hepatitis b
10/24/2000US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
10/24/2000US6136809 Azolo triazines and pyrimidines
10/24/2000US6136808 Antitumor agents from plants
10/24/2000US6136807 Mixture with acrylate polymers
10/24/2000US6136806 Remedy for rosacea
10/24/2000US6136805 Quinoxaline dione derivatives, their production and their use in medicaments
10/24/2000US6136803 Cycloalkyl ether indanamine compounds
10/24/2000US6136800 Steroids
10/24/2000US6136799 Cosolvent formulations
10/24/2000US6136797 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/24/2000US6136796 Drugs for antiischemic agents, strokes, antiepileptic agents and antiasthma agents
10/24/2000US6136793 Formulations containing hyaluronic acid
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136791 Viricides and anticarcinogenic agents
10/24/2000US6136790 Carbohydrate mimetics having antiadhesive properties
10/24/2000US6136780 Administering naltrexone or naloxone to treat gastrointestinal cancer, particularly colon or pancreatic cancer
10/24/2000US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents
10/24/2000US6136602 Nucleotide sequences which can hybridize to preferential target nucleic acids; for the suppression of the expression of genes associated with antibiotic resistance and the prevention of bacterial infections
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136574 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136367 Composition and its use as a food supplement or for lowering lipids in serum
10/24/2000US6136357 Anhydrous; cyclosporin; monoglycerides, diglycerides, and/or triglycerides of natural fatty acids; natural fatty acids and/or their alkaline salts; a substance containing 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine
10/24/2000US6136349 Food seasoning, food ingredients and food item compositions and methods for their preparation
10/24/2000US6136347 Drug as anhydrate of its base form microencapsulated in a coating of methyl or ethyl esters or quaternary ammonium compounds of polymethacrylic acid, or ethylcellulose, and triethyl citrate, optionally hydroxypropyl methyl cellulose
10/24/2000US6136345 Central core of amoxycillin(am) surrounded by a release retarding coating layer, and in a casing layer surrounding the core is am and clavulanate, initial quick release of am and clavulanate, and sustained release of am
10/24/2000US6136344 Oral pharmaceutical dosage form
10/24/2000US6136339 Administering for enhancing an athlete's muscle size or strength
10/24/2000US6136338 Given dosage of difloxacin or salt thereof in inert carrier
10/24/2000US6136336 JM216 formulations
10/24/2000US6136335 Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity
10/24/2000US6136333 By exposing tissue to chain extended, coupled or crosslinked polylactone-polyoxyalkylene glycol triblock or diblock having given ethylene oxide:lactoyl(ester) ratio, which provides a barrier to prevent or reduce the extent of adhesions forming
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000US6136317 Chromium picolinate compositions
10/24/2000US6136315 Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of neoplastic diseases
10/24/2000US6136310 Recombinant anti-CD4 antibodies for human therapy
10/24/2000US6136306 Treatment of a mammalian patient having a tumor by administering to the patient allogenic donor lymphocytes that have been co-cultured in the presence of the patient-derived lymphocytes under conditions sufficient to alloactivate the
10/24/2000US6136295 Biocompatible particles for delivery of a therapeutic, prophylactic or diagnostic agent to the pulmonary system comprising a therapeutic, prophylactic or diagnostic agent
10/24/2000US6136294 Amino acid stabilized medical aerosol formulation
1 ... 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 6237 6238 6239 6240 6241 6242 6243 ... 7860